Lack of diversity in clinical trials costs billions of dollars. Incentives can spur innovation
The lack of diversity in clinical trials unfairly skews American medicine and costs billions of dollars a year in early deaths and poor health. Proven economic incentives to recruit more diverse participants can dramatically change the bigger picture.continue reading on website
August 3, 2022